Table 1.

The characteristics of participants in studies depicted in Figures 1–4 and 8.

		Women				Men
		HIV- (n=235)		HIV+ ART+ (n=254)		HIV- (n=253)		HIV+ ART+ (n=243) 1
		n (%)	Median, IQR	n (%)	Median, IQR	n (%)	Median, IQR	n (%)	Median, IQR
Age (years)	≤45	33 (14.0%)	43 (5)	23 (9.1%)	44 (4)	17 (6.7%)	44 (2)	20 (8.2%)	44 (2.5)
	46–50	56 (23.8%)	48 (2)	50 (19.7%)	48 (2)	36 (14.2%)	48 (3)	43 (17.7%)	47 (3)
	51–55	55 (23.4%)	53 (2)	68 (26.8%)	53 (2)	54 (21.3%)	53 (3)	58 (23.9%)	53 (2)
	56–60	50 (21.3%)	58 (3)	59 (23.2%)	58 (3)	63 (24.9%)	58 (3)	54 (22.2%)	58 (2)
	61–65	35 (14.9%)	63 (3)	45 (17.7%)	62 (3)	49 (19.4%)	62 (3)	36 (14.8%)	63 (2)
	>66	6 (2.6%)	69 (6)	9 (3.5%)	71 (6)	34 (13.4%)	69 (4.5)	32 (13.2%)	68.5 (4)
Race	White, non-Hispanic	22 (9.4%)	-	30 (11.8%)	-	166 (65.6%)	-	128 (53%)	-
	White, Hispanic	12 (5.1%)	-	19 (7.5%)	-	11 (4.3%)	-	14 (6%)	-
	Black, non-Hispanic	175 (74.5%)	-	169 (66.5%)	-	68 (26.9%)	-	78 (32%)	-
	Black, Hispanic	4 (1.7%)	-	5 (2%)	-	2 (0.8%)	-	4 (2%)	-
	American Indian or Alaskan Native	1 (0.4%)	-	1 (0.4%)	-	1 (0.4%)	-	1 (0%)	-
	Asian or Pacific Islander	0 (0%)	-	0 (0%)	-	1 (0.4%)	-	1 (0%)	-
	Other	1 (0.4%)	-	1 (0.4%)	-	3 (1.2%)	-	2 (1%)	-
	Other Hispanic	20 (8.5%)	-	29 (11.4%)	-	1 (0.4%)	-	15 (6%)	-
BMI			30.5 (9.7)		30.3 (9.5)		26.2 (5.25)		25.5 (5.85)
Diabetes	No	162 (69.9%)	-	181 (71.3%)	-	196 (77.5%)	-	191 (79%)	-
	Yes	73 (31.1%)	-	73 (28.7%)	-	30 (11.9%)	-	34 (14%)	-
	Insufficient data	0 (0%)	-	0 (0%)	-	27 (10.7%)	-	18 (7%)	-
CD4 Count (cells/mm3)		-	-	-	725.5 (381.75)	-	-		698 (364)
Viral Load (copies/ml)		-	-	254 (100%)	<50	-	-	243 (100%)	<50
Nadir CD4 (cells/mm3)		-	-	-	216 (213.75)	-	-	-	306.5 (234)